Epigallocatechin gallate inhibits HeLa cells by modulation of epigenetics and signaling pathways
Related Experiment Video
Updated: Dec 3, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Madhumitha Kedhari Sundaram1, Shafiul Haque2, Pallavi Somvanshi3
1School of Life Sciences, Manipal Academy of Higher Education, PO Box 345050, Dubai, United Arab Emirates.
Abstract:
This study examines the effect of epigallocatechin gallate (EGCG) on signaling pathways, epigenetic modulators and tumour suppressor genes in cervical cancer cells, HeLa. qRT-PCR, ELISA-based enzymatic assays and in silico studies were used to catalogue the modulation of these genes by EGCG treatment. qRT-PCR showed transcriptional modulation of several epigenetic modifiers including DNA methyltransferases and histone modifiers (DNMT1, DNMT3B, DNMT3A, AURKA, AURKC, AURKB, KDM4A, KDM5C, PRMT7, PRMT6, UBE2B, HDAC5, HDAC6, HDAC7 and HDAC11. Furthermore, ELISA-based assays showed that EGCG lowered the activity of DNA methyltransferases, histone deacetylases and histone methyltransferases (H3K9). Molecular docking results suggests that EGCG may competitively inhibit some epigenetic enzymes (DNMT1, DNMT3A, HDAC2, HDAC3, HDAC4, HDAC7 and EZH2). A functional outcome of these epigenetic alterations could be inferred from the reversal of promoter hypermethylation of tumour suppressor genes by quantitative methylation array and transcriptional re-expression of tumour suppressor genes including TP73, PTEN, SOCS1, CDH1, RARβ, and DAPK1 by qRT-PCR. Downregulation of key signaling moieties of PI3K, Wnt and MAPK pathways, cell cycle regulators, metastasis regulators and pro-inflammatory moieties including TERT, CCNB1, CCNB2, MMP2, MMP7. PIK3C2B, PIK3CA, MAPK8 and IL6 was also observed. In silico protein-protein interaction network analysis followed by KEGG analysis discerned the active participation of gene sets towards cancer pathways. This study comprehensively explains EGCG's anti-cancer mechanism via the synchronized transcriptional alteration of several molecular targets across different signaling pathways and reversal of tumour suppressor gene silencing through modulation of epigenetic enzymes.
Insights
Epigallocatechin gallate (EGCG) reverses cervical cancer cell growth by modulating epigenetic enzymes, reactivating tumor suppressor genes, and altering cancer-related signaling pathways. This natural compound shows significant anti-cancer potential through synchronized molecular targeting.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- Cervical cancer remains a significant global health challenge.
- Epigenetic dysregulation plays a crucial role in cancer development and progression.
- Natural compounds like epigallocatechin gallate (EGCG) are being investigated for their therapeutic potential.
Purpose of the Study:
- To investigate the anti-cancer effects of EGCG on cervical cancer cells (HeLa).
- To elucidate EGCG's impact on epigenetic modulators, signaling pathways, and tumor suppressor genes.
- To understand the molecular mechanisms underlying EGCG's anti-cancer activity.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to assess gene transcription.
- ELISA-based enzymatic assays to measure enzyme activity.
- In silico molecular docking and protein-protein interaction network analysis.
- Quantitative methylation array analysis.
Main Results:
- EGCG modulated the transcription of various epigenetic modifiers, including DNA methyltransferases and histone modifiers.
- EGCG reduced the activity of DNA methyltransferases, histone deacetylases, and histone methyltransferases.
- EGCG treatment led to the re-expression of silenced tumor suppressor genes (e.g., TP73, PTEN, SOCS1) by reversing promoter hypermethylation.
- EGCG downregulated key signaling pathways (PI3K, Wnt, MAPK), cell cycle regulators, metastasis, and pro-inflammatory factors.
- In silico analyses confirmed EGCG's potential to inhibit epigenetic enzymes and identified its role in cancer pathways.
Conclusions:
- EGCG exhibits anti-cancer properties in cervical cancer cells by targeting multiple molecular mechanisms.
- EGCG modulates epigenetic enzymes, leading to the reactivation of tumor suppressor genes.
- EGCG's synchronized alteration of signaling pathways and epigenetic landscape contributes to its anti-cancer effects.
More Related Videos
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
Related Concept Videos
Mitogens and the Cell Cycle
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply